Effect of TEAS Combined With Oxycodone on Postoperative Visceral Pain in Gynecologic Laparoscopic Patients
Launched by YANGZHOU UNIVERSITY · Jul 23, 2024
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a treatment called TEAS (transcutaneous electrical acupoint stimulation) combined with the pain medication oxycodone can help reduce pain after surgery in women who are having laparoscopic procedures. The goal is to find out if this combination is effective and to improve pain management for patients recovering from surgery.
To be eligible for this trial, participants must be women aged 18 to 65 years who are generally healthy, with a body mass index (BMI) between 18.5 and 30. They should not have any infections where the acupuncture will be applied or serious health issues related to the heart, lungs, liver, or kidneys. If you join the study, you can expect to receive either the TEAS treatment, oxycodone, or a combination of both to help manage your pain after surgery. The trial is currently looking for participants, so if you meet the criteria and are interested, you may want to reach out for more information.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Age 18-65 years
- • American Society of Anesthesiologists grade I-II
- • Body mass index (BMI) 18.5-30 kg/m2;
- • No ulceration or infection at the acupuncture stimulation site.
- Exclusion Criteria:
- • Allergic to the drugs used in the study;
- • People with unclear consciousness or cognitive dysfunction;
- • There are contraindications of percutaneous acupoint electrical stimulation;
- • Abnormal cardiopulmonary and liver and kidney function;
- • History of analgesic drug use within one week;
- • History of diabetes, myocardial infarction or cerebrovascular accident.
About Yangzhou University
Yangzhou University is a prestigious educational and research institution located in Yangzhou, China, dedicated to advancing knowledge and innovation in various fields, including medicine and healthcare. As a clinical trial sponsor, Yangzhou University leverages its extensive academic resources and expertise to conduct high-quality research aimed at improving patient outcomes and contributing to the scientific community. The university fosters collaboration among multidisciplinary teams and emphasizes ethical practices and regulatory compliance in its clinical research endeavors, ensuring the integrity and reliability of its findings. Through its commitment to excellence, Yangzhou University strives to enhance the understanding of health-related issues and develop effective interventions that benefit society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Yangzhou, Jiangsu, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported